The Science Behind the Nobel-Winning Technology That Controls Neurons With Light
Optogenetics revolutionized neuroscience, but its origins come from an entirely brainless organism - an alga.


Glideslope AI-powered market news
1 stories in the last 7 days. Quiet in the last 24 hours.

| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 1 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
Optogenetics revolutionized neuroscience, but its origins come from an entirely brainless organism - an alga.

The device made by Flow Neuroscience is approved by the FDA and could help people get off antidepressants - but it costs $2,200.
.jpg)
ABBV's neuroscience unit delivered $10.8B in 2025 and can hit $12.5B in 2026 as Vyalev gains traction and new Parkinson's drug tavapadon awaits FDA review.
Flow Neuroscience has announced FDA approval of their breakthrough Flow at-home brain-stimulation device for the treatment of major depressive disorder (MDD).…

Firefly Neuroscience corrects payment terms in Evoke acquisition press release, confirming earn-out paid in common stock.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE